Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Ambulatory Gastric Potential Hydrogen (pH) in Patients Suffering From Acid Peptic Disorder After Single and Repeated Dosing.

Trial Profile

Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Ambulatory Gastric Potential Hydrogen (pH) in Patients Suffering From Acid Peptic Disorder After Single and Repeated Dosing.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Gastritis; Peptic ulcer; Reflux oesophagitis
  • Focus Therapeutic Use
  • Acronyms D-TAPeD
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 01 Nov 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
    • 01 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Apr 2011 Planned end date changed from 1 Jun 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top